Sofia Nikou

Sofia Nikou

Auto-generated profile, based on publicly available information

Sofia Nikou

Department of Anatomy-Histology-Embryology, School of Medicine, University of Patras, Patras, Greece

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2018 in Cancer Genomics & Proteomics
Verified
Journal Article
Open access
PDF file
DTDimitrios Tsoumas
Dimitrios Tsoumas
SNSofia Nikou
Sofia Nikou
EGEfstathia Giannopoulou
Efstathia Giannopoulou
STSpyridon Champeris Tsaniras
Spyridon Champeris Tsaniras
CSChaido Sirinian
Chaido Sirinian
VBVasiliki Bravou
Vasiliki Bravou
Background/Aim: Epithelial-mesenchymal transition (EMT) and cancer stem cells (CSC) are critically implicated in cancer metastasis and chemoresistance. Herein, we investigated integrin-linked kinase (ILK)'s role in human colon cancer (CRC) progression and chemoresistance in relation to EMT and CSC markers. Patients and Methods: Expression of ILK, EMT and CSC markers were evaluated by immunohistochemistry in 149 CRC samples. We also generated colon cancer cells resistant to 5-FU and oxaliplatin and studied the effect of ILK inhibition on drug response by MTT assay and on EMT and CSC markers' expression. Results: ILK expression in human CRC correlates with EMT and CSC markers and is associated with metastasis and chemoresistance. ILK inhibition increases sensitivity of resistant cells to 5-FU and oxaliplatin and reduces the levels of EMT and CSC markers in 5-FU resistant cells. Conclusion: ILK overexpression in human CRC associates with EMT and CSC traits, contributing to tumor progression and chemoresistance.

19 January 2018 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
HAHelen Aggelou
Helen Aggelou
PCPanagiota Chadla
Panagiota Chadla
SNSofia Nikou
Sofia Nikou
SKSofia Karteri
Sofia Karteri
IMIoannis Maroulis
Ioannis Maroulis
VBVasiliki Bravou
Vasiliki Bravou

21 August 2018 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
STSpyridon Champeris Tsaniras
Spyridon Champeris Tsaniras
MVMaria Villiou
Maria Villiou
AGAnastassios D Giannou
Anastassios D Giannou
SNSofia Nikou
Sofia Nikou
MPMichalis Petropoulos
Michalis Petropoulos
Stavros TaravirasStavros Taraviras
Stavros Taraviras

1 June 2021 in Analytica Chimica Acta
Verified
Journal Article
Closed access
Panagiota M KalligosfyriPanagiota M Kalligosfyri
Panagiota M Kalligosfyri
SNSofia Nikou
Sofia Nikou
VBVasiliki Bravou
Vasiliki Bravou
Despina KalogianniDespina Kalogianni
Despina Kalogianni

9 January 2019 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
APAristea Psilopanagioti
Aristea Psilopanagioti
SNSofia Nikou
Sofia Nikou
HPHelen Papadaki
Helen Papadaki
Background/Aims: Nesfatin-1, processed from nucleobindin-2 (NUCB2), is a potent anorexigenic peptide being expressed in rodent hypothalamic nuclei and involved in the regulation of feeding behavior and body weight in animals. The present study aimed to investigate NUCB2/nesfatin-1 protein expression in the human hypothalamus as well as its correlation with body weight. Methods: Sections of hypothalamus and adjacent cholinergic basal forebrain nuclei, including the nucleus basalis of Meynert (NBM) and the diagonal band of Broca (DBB), from 25 autopsy cases (17 males, 8 females; 8 lean, 9 overweight, 8 obese) were examined using immunohistochemistry and double immunofluorescence labeling. Results: Prominent NUCB2/nesfatin-1 immunoexpression was detected in supraoptic, paraventricular, and infundibular nuclei, lateral hypothalamic area (LHA)/perifornical region, and NBM/DBB. NUCB2/nesfatin-1 was found to extensively colocalize with (a) oxytocin and vasopressin in paraventricular and supraoptic nuclei, (b) melanin-concentrating hormone in the LHA, and (c) cocaine- and amphetamine-regulated transcript in infundibular and paraventricular nuclei and LHA. Interestingly, in the LHA, NUCB2/nesfatin-1 protein expression was significantly decreased in obese, compared with lean (p < 0.01) and overweight (p < 0.05) subjects. Conclusions: The findings of the present study are suggestive of a potential role for NUCB2/nesfatin-1 as an integral regulator of food intake and energy homeostasis in the human hypothalamus. In the LHA, an appetite- and reward-related brain area, reduced NUCB2/nesfatin-1 immunoexpression may contribute to dysregulation of homeostatic and/or hedonic feeding behavior and obesity. NUCB2/nesfatin-1 localization in NBM/DBB might imply its participation in the neuronal circuitry controlling cognitive influences on food intake and give impetus towards unraveling additional biological actions of NUCB2/nesfatin-1 in human neuronal networks.

12 June 2015 in Cancer Investigation
Verified
Journal Article
Closed access
PDF file
VBVasiliki Bravou
Vasiliki Bravou
AAAnna Antonacopoulou
Anna Antonacopoulou
SPSofia Papanikolaou
Sofia Papanikolaou
SNSofia Nikou
Sofia Nikou
ILIoannis Lilis
Ioannis Lilis
HKHaralabos P. Kalofonos
Haralabos P. Kalofonos
This study aims to address the role of focal adhesion proteins α- and β-parvin in human colorectal carcinoma (CRC). Expression of α- and β-parvin was examined by immunohisto- chemistry and real-time RT-PCR in a series of human CRC. Parvins were overexpressed in CRC and their expression correlated significantly with tumor invasion, lymph node metastasis, and disease stage. A significant positive correlation of parvins protein expression with overexpression of integrin-linked kinase, p-AKT, and nuclear β-catenin, as well as with downregulation of E-cadherin was also observed. In conclusion, overexpression of α- and β-parvin seems to be implicated in human colorectal cancer progression.